Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 918 | 882 | 943 | 1064 | 1283 | 1725 |
Fund Return | -8.17% | -11.76% | -5.71% | 2.08% | 5.11% | 5.6% |
Place in category | 413 | 529 | 556 | 197 | 163 | 157 |
% in Category | 50 | 59 | 68 | 41 | 40 | 58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
EdR Fund Big Data I USD | 2.02B | 11.24 | 12.66 | - | ||
Melchior Selected Trust European Ou | 490.31M | 5.20 | 2.13 | 6.02 | ||
EdR Fund US Value N USD | 336.41M | -0.20 | 21.17 | - | ||
EdR Fund US Value I USD | 336.41M | -0.39 | 20.78 | 5.50 | ||
EdR Fund US Value R USD | 336.41M | -1.54 | 19.11 | 4.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund C2u | 371.38M | 8.06 | 4.75 | 8.07 | ||
World Healthscience Fund D2u | 1.31B | 8.57 | 6.87 | 10.25 | ||
World Healthscience Fund X2 USD | 37.03M | 8.85 | 7.92 | 11.35 | ||
World Healthscience Fund A2 | 6.75B | 8.38 | 6.07 | 9.43 | ||
World Healthscience Fund E2 | 2.11B | 8.25 | 5.55 | 8.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Pfizer | US7170811035 | 5.24 | 25.64 | +0.94% | |
CVS Health Corp | US1266501006 | 5.08 | 67.45 | +0.40% | |
Eli Lilly | US5324571083 | 4.83 | 737.20 | +0.50% | |
AstraZeneca | GB0009895292 | 4.02 | 12,024.0 | +0.30% | |
Edmond de Rothschild Credit Very Short Term C | FR0010027623 | 3.93 | 130.123 | +0.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review